Hypoglycemic activity of Phaseolus vulgaris (L.) aqueous extract in type 1 diabetic rats

1. IDF Diabetes Atlas 7th Edition 2015. Available: https://www.idf.org/e-library/epidemiology-research/diabetes-atlas/13-diabetes-atlas-seventh-edition.html Search in Google Scholar

2. Blair M. Diabetes Mellitus Review. Urol Nurs. 2016;36(1):27-36.10.7257/1053-816X.2016.36.1.27 Search in Google Scholar

3. Brealey D, Singer M. Hyperglycemia in critical illness: a review. J Diabetes Sci Technol. 2009;3(6):1250-60.10.1177/193229680900300604278702420144378 Search in Google Scholar

4. Dias DA, Urban S, Roessner U. A Historical Overview of Natural Products in Drug Discovery. Metabolites. 2012;2(2):303-36.10.3390/metabo2020303390120624957513 Search in Google Scholar

5. Chang CL, Chen YC, Chen HM, et al. Natural cures for type 1 diabetes: a review of phytochemicals, biological actions, and clinical potential. Curr Med Chem. 2013;20(7):899-907.10.2174/0929867311320070006 Search in Google Scholar

6. Yeh GY, Eisenberg DM, Kaptchuk TJ, et al. Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care. 2003;26(4):1277-94.10.2337/diacare.26.4.127712663610 Search in Google Scholar

7. Covington MB. Traditional Chinese medicine in the treatment of diabetes. Diabetes Spectr. 2001;14:154-9.10.2337/diaspect.14.3.154 Search in Google Scholar

8. Ota A, Ulrih NP. An overview of herbal products and secondary metabolites used for management of type two diabetes. Front Pharmacol. 2017;8:436.10.3389/fphar.2017.00436549930828729836 Search in Google Scholar

9. Pandey VN, Rajagopalan SS, Chowdhary DP. An effective Ayurvedic hypoglycemic formulation. J Res Ayurveda Siddha. 1995;1-14. Search in Google Scholar

10. Oubre AY, Carlson TJ, King SR, et al. From plant to patient: an ethnomedical approach to the identification of new drugs for the treatment of NIDDM. Diabetologia. 1997;40:614-17.10.1007/s0012500507249165233 Search in Google Scholar

11. Karimi A, Majlesi M, Rafieian-Kopaei M. Herbal versus synthetic drugs; beliefs and facts. J Nephropharmacol. 2015;4(1):27-30. Search in Google Scholar

12. Bharti SK, Krishnan S, Kumar A, et al. Antidiabetic phyto-constituents and their mode of action on metabolic pathways. Ther Adv Endocrinol Metab. 2018;9(3):81-100.10.1177/2042018818755019581385929492244 Search in Google Scholar

13. Chávez-Mendoza C, Sánchez E. Bioactive compounds from Mexican varieties of the Common Bean (Phaseolus vulgaris): implications for health. Molecules. 2017;22(8),1360.10.3390/molecules22081360 Search in Google Scholar

14. Reynoso-Camacho R., Ramos-Gomez M., Loarca-Pina G. Bioactive components in common beans (Phaseolus vulgaris L.). Research Signpost. 2006;37/661(2):217-36. Search in Google Scholar

15. Helmstädter A. Beans and diabetes: Phaseolus vulgaris preparations as antihyperglycemic agents. J Med Food. 2010;13(2):251-4.10.1089/jmf.2009.000220132042 Search in Google Scholar

16. Zafar M, Naqvi S. Effects of STZ-induced diabetes on the relative weights of kidney, liver and pancreas in Albino rats: A comparative study. Int J Morphol. 2010;28(1):135-42.10.4067/S0717-95022010000100019 Search in Google Scholar

17. Sabu MC, Subburaju T. Effect of Cassia auriculata Linn. on serum glucose level, glucose utilization by isolated rat hemidiaphragm. J Ethnopharmacol. 2002;80:203-6.10.1016/S0378-8741(02)00026-0 Search in Google Scholar

18. Stasevych M, Zvarych V, Lunin V, et al. Novel anthraquinone-based derivatives as potent inhibitors for receptor tyrosine kinases. Indian J Pharm Sci. 2015;77(5):634-7.10.4103/0250-474X.169062 Search in Google Scholar

19. Carai MAM, Fantini N, Loi B, et al. Potential efficacy of preparations derived from Phaseolus vulgaris in the control of appetite, energy intake, and carbohydrate metabolism. Diabetes Metab Syndr Obes. 2009;2:145-53.10.2147/DMSO.S4236 Search in Google Scholar

20. Roman-Ramos R, Flores-Saenz JL, Partida-Hernandez G, et al. Experimental study of the hypoglycemic effect of some edible plants. Arch Invest Med (Mex). 1991;22:87-93. Search in Google Scholar

21. Roman-Ramos R, Flores-Saenz JL, Alarcon-Aguilar F. Antihyperglycemic effect of some edible plants. J Ethnopharmacol. 1995;48:25-32.10.1016/0378-8741(95)01279-M Search in Google Scholar

22. Pari L, Venkateswaran S. Effect of an aqueous extract of Phaseolus vulgaris on plasma insulin and hepatic key enzymes of glucose metabolism in experimental diabetes. Pharmazie. 2003;58:916-9. Search in Google Scholar

23. Almuaigela MF, Seifb MA, Albualia HW, Alharbia O, Alhawasha A. Hypoglycemic and hypolipidemic effects of aqueous extract of phaseolus vulgaris pods in streptozotocin-diabetic rats. Biomedicine & Pharmacotherapy. 2017; 94:742-6.10.1016/j.biopha.2017.07.13528800543 Search in Google Scholar

24. Pari L, Venkateswaran S. Protective role of Phaseolus vulgaris on changes in the fatty acid composition in experimental diabetes. J Med Food. 2004;7(2):204-9.10.1089/109662004122412015298769 Search in Google Scholar

25. Neef H, Declercq P, Laekeman G. Hypoglycemic activity of selected European plants. Phytother Res. 1995;9:45-8.10.1002/ptr.2650090111 Search in Google Scholar

26. Cerovic A, Miletic I, Konic.-Ristic A, et al. The dry plant extract of common bean seed (Phaseoli vulgari pericarpium) does not have an affect on postprandial glycemia in healthy human subject. Bosn J Basic Med Sci. 2006;6(3):28-33.10.17305/bjbms.2006.3140719365716995844 Search in Google Scholar

27. Kyznetsova MY, Lavrovska DO, Zhyvolozhnyi AY, et al. Effect of aqueous extract from Phaseolus vulgaris pods on cytokine profile of streptozotocin-induced diabetic rats. RJPBCS. 2015;6(1):1511-20. Search in Google Scholar

28. Kyznietsova MY, Halenova TI, Savchuk OM, et al. Carbohydrate metabolism in type 1 diabetic rats under the conditions of the kidney bean pods aqueous extract application. Fiziol Zh. 2015;61(6):96-103.10.15407/fz61.06.09627025050 Search in Google Scholar

29. Kyznetsova M, Makieieva O, Lavrovska D, et al. Aqueous extract from Phaseolus vulgaris pods on lipid peroxidation and antioxidant enzymes activity in the liver and kidney of diabetic rats. J Appl Pharm Sci. 2015; 5(5):001-6.10.7324/JAPS.2015.50501 Search in Google Scholar

30. Oseguera Toledo ME, Gonzalez de Mejia E, Sivaguru M, et al. Common bean (Phaseolus vulgaris L.) protein-derived peptides increased insulin secretion, inhibited lipid accumulation, increased glucose uptake and reduced the phosphatase and tensin homologue activation in vitro. J Funct Foods. 2016; 27:160-77.10.1016/j.jff.2016.09.001 Search in Google Scholar

31. Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia. 2008;51(2):216-26.10.1007/s00125-007-0886-718087688 Search in Google Scholar

32. Lim M, Park L, Shin G, Hong H, Kang I, Park Y. Induction of apoptosis of Beta cells of the pancreas by advanced glycation end-products, important mediators of chronic complications of diabetes mellitus. Ann NY Acad Sci. 2008;1150:311-5.10.1196/annals.1447.01119120318 Search in Google Scholar

33. Barrett ML, Udani JK. A proprietary alpha-amylase inhibitor from white bean (Phaseolus vulgaris): a review of clinical studies on weight loss and glycemic control. Nutr J. 2011;10:24.10.1186/1475-2891-10-24307177821414227 Search in Google Scholar

34. Baintner K, Kiss P, Pfüller U, et al. Effect of orally and intraperitoneally administered plant lectins on food consumption of rats. Acta Physiol Hung. 2003; 90(2):97-107.10.1556/APhysiol.90.2003.2.212903908 Search in Google Scholar